Named on 3 rounds in the feed, most often at Series A and in Biotech.
Rounds from 2022-07-20 to 2026-09-29
ROUNDS
3
led 1, joined 2
LED ROUNDS · USD
$35.5M
across 1 round · 1 co-led, split evenly
CO-INVESTORS
19
named beside it
Named on 3 rounds in the feed, most often at Series A and in Biotech.
Rounds from 2022-07-20 to 2026-09-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Breye Therapeutics A clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases | Series A Verified against 4 of 11 sources | $75.8M | 2026-09-29 | [ PART ] |
AnaCardio A clinical-stage biopharmaceutical company developing novel therapies for heart failure | Series B Verified against 1 of 17 sources | $71.0M | 2026-09-29 | [ LEAD ] |
Forsight Robotics The JASPER™ Robotic Surgery Platform which enhances eye surgery for patients and surgeons. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $55M | 2022-07-20 | [ PART ] |